Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website http://www.jofem.org |
Original Article
Volume 8, Number 5, October 2018, pages 100-105
Evaluation of Clinical and Microbiological Characteristics of Foot Infections of Patients With Diabetes: Does Antibiotic Susceptibility Change?
Tables
N (%) | Mean ± SD | |
---|---|---|
*No patients in Wagner stages 0 and 1. | ||
Age (year) | 63.1 ± 10.9 | |
Duration of diabetes (year) | 16.9 ± 6.9 | |
Gender | ||
Female | 12 (23.5%) | |
Male | 39 (77.5%) | |
Neuropathy | 50 (98%) | |
Nephropathy | 44 (86%) | |
Retinopathy | 48 (94%) | |
Peripheral arterial disease | 40 (78.4%) | |
Wagner stage* | ||
Wagner 2 | 5 (9.6%) | |
Wagner 3 | 33 (63.5%) | |
Wagner 4 | 14 (26.9%) | |
Osteomyelitis | 47 (90.4%) | |
Amputation | 46 (90.1%) |
Bacteria | Total (N) |
---|---|
Gram-positive microorganisms | 96 |
Enterococcus faecalis | 28 |
Staphylococcus aureus | 23 |
Staphylococcus epidermidis | 18 |
Other CNS | 9 |
Streptococcus agalactiae | 8 |
Streptococcus dysgalactiae | 4 |
Streptococcus viridans | 3 |
Enterococcus avium | 2 |
Streptococcus pyogenes | 1 |
Gram-negative microorganisms | 101 |
Pseudomonas aeruginosa | 16 |
Morganella morganii | 15 |
Escherichia coli | 13 |
Acinetobacter baumannii | 11 |
Proteus mirabilis | 11 |
Serratia marcescens | 6 |
Klebsiella pneumoniae | 5 |
Citrobacter koseri | 4 |
Providencia rettgeri | 3 |
Klebsiella oxytoca | 2 |
Citrobacter braakii | 2 |
Citrobacter freundii | 2 |
Enterobacter cloacae | 2 |
Stenotrophomonas maltophilia | 3 |
Proteus penneri | 1 |
Proteus vulgaris | 1 |
Providencia alcalifaciens | 1 |
Providencia stuartii | 1 |
Serratia liquefaciens | 1 |
Sphingomonas paucimobilis | 1 |
Fungi | |
Candida species | 1 |
Total | 207 |
Characteristic of reproduction | Number (N) | Amputation N (%) | Osteomyelitis N (%) |
---|---|---|---|
Mono microbial | 85 | 74 (87%) | 54 (64%) |
Gram-positive | 43 | ||
Gram-negative | 42 | ||
Poly microbial | 54 | 52 (98%) | 40 (75%) |
All are Gram-positive | 12 | ||
All are Gram-negative | 7 | ||
Mixed | 35 |
Microorganism | Type of resistance | Resistance (N)/total (N) (%) |
---|---|---|
In S. aureus | ||
Methicillin resistance | 5/11 (45%) | |
Quinolone resistance | 7/20 (35%) | |
TMP/SMX resistance | 2/15 (13%) | |
Clindamycin resistance | 7/15 (47%) | |
In CNS | ||
Methicillin resistance | 19/22 (86%) | |
In Enterobacteriaceae | ||
ESBL positivity | 5/12 (42%) | |
Quinolone resistance | 25/34 (74%) | |
P. aeruginosa | ||
Carbapenem resistance | 6/17 (35%) | |
Quinolone resistance | 6/15 (40%) | |
Aminoglycoside resistance | 3/15 (20%) | |
In Enterococcus species | ||
Ampicillin resistance | 12/30 (40%) | |
Vancomycin resistance | 0/27 (0%) | |
In A. baumannii | ||
Carbapenem resistance | 8/11 (73%) | |
Aminoglycoside resistance | 6/11 (55%) |